meta_pixel
Tapesearch Logo
Log in
WSJ Tech News Briefing

Instacart IPO: Lessons and Losses for Investors

WSJ Tech News Briefing

The Wall Street Journal

Tech News, News

4.31.7K Ratings

🗓️ 19 September 2023

⏱️ 12 minutes

🧾️ Download transcript

Summary

Instacart is set to go public at a valuation less than one quarter of its peak a few years ago. WSJ reporter Berber Jin joins host Zoe Thomas to explain why this spells losses for venture capital investors and what lessons VCs and startups are taking away. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

This podcast is brought to you by Koveo AI.

0:02.7

Gen AI is a make or break moment for enterprises,

0:05.2

and after a decade of deploying AI with leading brands, Koveo knows exactly how to help.

0:09.7

Koveo Generate of Answering is secure, accurate, and enterprise-ready.

0:13.3

Visit Koveo.com to learn more.

0:19.6

Welcome to Tech News Briefing. It's Tuesday, September 19.

0:23.6

I'm Zoe Thomas for the Wall Street Journal.

0:26.7

Grocery Delivery took off during the pandemic,

0:30.0

helping to skyrocket the value of the startup Instacart.

0:34.2

But the economic situation has changed,

0:36.9

and as Instacart prepares to go public today,

0:39.8

some of its biggest venture capital investors are preparing for losses.

0:44.9

Reporter Berber Gin who covers VCs is going to join us to explain

0:48.7

what's happening with Instacart and its wider ramifications for tech startups.

0:56.1

But first, Elon Musk met with Israeli Prime Minister Benjamin Netanyahu yesterday,

1:01.8

and broadcast the conversation on the platform formerly known as Twitter.

1:06.7

Musk asked the Israeli leader about developments in artificial intelligence,

1:10.7

which Netanyahu said was a double-edged sword.

1:13.9

The blessings of AI are amazing, and we see them already.

1:19.1

In Israel, we see them around the world.

1:21.6

You can see the addition of decades of life to the human lifespan,

1:26.8

precision medicine dedicated to every person's genetic composition,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.